Compounds > ephedrine
Page last updated: 2024-08-21

ephedrine and Muscle Weakness

ephedrine has been researched along with Muscle Weakness in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barros-Angueira, F; Eirís-Puñal, J; Fuentes-Pita, P; Gómez-Lado, C; López-Vázquez, A; Pardo, J; Pérez-Gay, L; Quintas-Rey, R1
Allen, D; Arunachalam, R; Beeson, D; Burke, G; Hammans, S1
Abicht, A; Barisic, N; Deschauer, M; Lindberg, C; Lochmüller, H; Müller, JS; Schara, U; Straub, V; Strigl-Pill, N; Wendt, M1
Haran, G; Haran, M; Mate, A; Schattner, A; Shtalrid, M; Starobin, D1
Abicht, A; Lochmüller, H; Mahjneh, I; Muntoni, F1
BOUDIN, G; GOULON, M; HAMBURGER, J; LAPRESLE, J; LHERMITTE, F; PEQUIGNOT, H1

Other Studies

6 other study(ies) available for ephedrine and Muscle Weakness

ArticleYear
Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome.
    Revista de neurologia, 2020, Sep-16, Volume: 71, Issue:6

    Topics: Alleles; Child; Electromyography; Ephedrine; Female; Heterozygote; Humans; Muscle Weakness; Mutation, Missense; Myasthenic Syndromes, Congenital; Phenotype; Point Mutation; Pyridostigmine Bromide; Receptors, Nicotinic

2020
A treatable muscle disease.
    Practical neurology, 2009, Volume: 9, Issue:4

    Topics: Age Distribution; Aged; Disease Progression; Ephedrine; Extremities; Female; Gait Disorders, Neurologic; Genetic Predisposition to Disease; Horner Syndrome; Humans; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Myasthenic Syndromes, Congenital; Neuromuscular Junction

2009
Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
    Neuromuscular disorders : NMD, 2009, Volume: 19, Issue:12

    Topics: Adolescent; Adult; Child; Cohort Studies; Ephedrine; Face; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Proteins; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Prospective Studies; Severity of Illness Index; Sympathomimetics; Treatment Outcome

2009
Can a rare form of myasthenia gravis shed additional light on disease mechanisms?
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:5

    Topics: Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Autoantibodies; Calcium Signaling; Carbon Dioxide; Diaphragm; Dyspnea; Electric Stimulation; Electromyography; Ephedrine; Humans; Male; Muscle Weakness; Myasthenia Gravis; Plasma Exchange; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Speech Disorders

2013
DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.
    Neuromuscular disorders : NMD, 2013, Volume: 23, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Diagnosis, Differential; Ephedrine; Female; Humans; Male; Middle Aged; Muscle Proteins; Muscle Strength; Muscle Weakness; Muscular Dystrophies, Limb-Girdle; Mutation; Myasthenic Syndromes, Congenital; Pakistan; Treatment Outcome

2013
[HOW TO TREAT MYASTHENIA].
    La Presse medicale, 1964, Oct-10, Volume: 72

    Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmine; Prognosis; Pyridostigmine Bromide; Respiratory Insufficiency; Spironolactone; Surgical Procedures, Operative; Thymus Neoplasms

1964